new scientist has received an unprecedented amount of interest in this story from readers. if you would like up-to-date information on any plans for clinical trials of dca in patients with cancer, or would like to donate towards a fund for such trials, please visit the site set up by the university of alberta and the alberta cancer board. we will also follow events closely and will report any progress as it happens.
it sounds almost too good to be true: a cheap and simple drug that kills almost all cancers by switching off their "immortality". the drug, dichloroacetate (dca), has already been used for years to treat rare metabolic disorders and so is known to be relatively safe.
it also has no patent, meaning it could be manufactured for a fraction of the cost of newly developed drugs.
evangelos michelakis of the university of alberta in edmonton, canada, and his colleagues tested dca on human cells cultured outside the body and found that it killed lung, breast and brain cancer cells, but not healthy cells. tumours in rats deliberately infected with human cancer also shrank drastically when they were fed dca-laced water for several weeks.
dca attacks a unique feature of cancer cells: the fact that they make their energy throughout the main body of the cell, rather than in distinct organelles called mitochondria. this process, called glycolysis, is inefficient and uses up vast amounts of sugar.
until now it had been assumed that cancer cells used glycolysis because their mitochondria were irreparably damaged. however, michelakis's experiments prove this is not the case, because dca reawakened the mitochondria in cancer cells. the cells then withered and died (cancer cell
, doi: 10.1016/j.ccr.2006.10.020).